Portfolio will address industry’s demand for additional services that revolve around personalized patient treatments.
The airline’s new portfolio features its current pharma transport solutions, alongside two new concepts: Emirates Vital and Emirates Medical Devices, which were both developed after receiving customer feedback. The Emirates SkyCargo team is currently working closely with specialist freight forwarders globally to roll out these new services.
“ … By listening to our customers, we saw an opportunity to support the global health industry’s advances in personalized patient treatments and meet the growing need for priority services in air cargo logistics to move sensitive materials and equipment—for instance, those used in the research of sophisticated therapies like gene editing and cell therapy,” says Nabil Sultan, the company’s divisional SVP. “ We are on a mission to help the world work better, not only for our customers, but also for their end customers—individual patients.